vs

Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and Oil-Dri Corp of America (ODC). Click either name above to swap in a different company.

Oil-Dri Corp of America is the larger business by last-quarter revenue ($120.5M vs $83.5M, roughly 1.4× BillionToOne, Inc.). Oil-Dri Corp of America runs the higher net margin — 12.8% vs 6.8%, a 6.0% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs -5.8%). BillionToOne, Inc. produced more free cash flow last quarter ($6.5M vs $1.3M).

BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.

Oil-Dri Corporation of America is a leading manufacturer and marketer of specialty sorbent and clay-based products. Its offerings include industrial spill cleanup absorbents, pet care goods such as cat litter, agricultural soil amendments, and sports field conditioning materials, serving customers across North America and other global commercial markets.

BLLN vs ODC — Head-to-Head

Bigger by revenue
ODC
ODC
1.4× larger
ODC
$120.5M
$83.5M
BLLN
Growing faster (revenue YoY)
BLLN
BLLN
+123.2% gap
BLLN
117.4%
-5.8%
ODC
Higher net margin
ODC
ODC
6.0% more per $
ODC
12.8%
6.8%
BLLN
More free cash flow
BLLN
BLLN
$5.2M more FCF
BLLN
$6.5M
$1.3M
ODC

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
BLLN
BLLN
ODC
ODC
Revenue
$83.5M
$120.5M
Net Profit
$5.7M
$15.5M
Gross Margin
69.9%
29.5%
Operating Margin
11.5%
14.1%
Net Margin
6.8%
12.8%
Revenue YoY
117.4%
-5.8%
Net Profit YoY
138.3%
-5.6%
EPS (diluted)
$0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLLN
BLLN
ODC
ODC
Q4 25
$120.5M
Q3 25
$83.5M
$125.2M
Q2 25
$115.5M
Q1 25
$116.9M
Q4 24
$127.9M
Q3 24
$38.4M
$113.7M
Q2 24
$106.8M
Q1 24
$105.7M
Net Profit
BLLN
BLLN
ODC
ODC
Q4 25
$15.5M
Q3 25
$5.7M
$13.1M
Q2 25
$11.6M
Q1 25
$12.9M
Q4 24
$16.4M
Q3 24
$-14.9M
$8.5M
Q2 24
$7.8M
Q1 24
$12.4M
Gross Margin
BLLN
BLLN
ODC
ODC
Q4 25
29.5%
Q3 25
69.9%
27.8%
Q2 25
28.6%
Q1 25
29.5%
Q4 24
31.9%
Q3 24
52.6%
29.0%
Q2 24
28.2%
Q1 24
29.3%
Operating Margin
BLLN
BLLN
ODC
ODC
Q4 25
14.1%
Q3 25
11.5%
12.5%
Q2 25
12.0%
Q1 25
15.0%
Q4 24
16.6%
Q3 24
-32.9%
11.3%
Q2 24
9.8%
Q1 24
14.4%
Net Margin
BLLN
BLLN
ODC
ODC
Q4 25
12.8%
Q3 25
6.8%
10.4%
Q2 25
10.1%
Q1 25
11.1%
Q4 24
12.8%
Q3 24
-38.8%
7.5%
Q2 24
7.3%
Q1 24
11.7%
EPS (diluted)
BLLN
BLLN
ODC
ODC
Q4 25
Q3 25
$0.10
Q2 25
Q1 25
Q4 24
Q3 24
$-1.47
Q2 24
Q1 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLLN
BLLN
ODC
ODC
Cash + ST InvestmentsLiquidity on hand
$195.2M
$42.4M
Total DebtLower is stronger
$55.0M
Stockholders' EquityBook value
$-239.5M
$266.5M
Total Assets
$327.5M
$380.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLLN
BLLN
ODC
ODC
Q4 25
$42.4M
Q3 25
$195.2M
$50.5M
Q2 25
$36.5M
Q1 25
$22.6M
Q4 24
$12.5M
Q3 24
$23.5M
Q2 24
$46.8M
Q1 24
$27.8M
Total Debt
BLLN
BLLN
ODC
ODC
Q4 25
Q3 25
$55.0M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
BLLN
BLLN
ODC
ODC
Q4 25
$266.5M
Q3 25
$-239.5M
$259.1M
Q2 25
$246.9M
Q1 25
$235.9M
Q4 24
$224.0M
Q3 24
$-242.9M
$210.6M
Q2 24
$202.9M
Q1 24
$196.0M
Total Assets
BLLN
BLLN
ODC
ODC
Q4 25
$380.7M
Q3 25
$327.5M
$391.7M
Q2 25
$369.5M
Q1 25
$353.7M
Q4 24
$350.2M
Q3 24
$354.6M
Q2 24
$319.2M
Q1 24
$296.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLLN
BLLN
ODC
ODC
Operating Cash FlowLast quarter
$13.8M
$10.3M
Free Cash FlowOCF − Capex
$6.5M
$1.3M
FCF MarginFCF / Revenue
7.7%
1.1%
Capex IntensityCapex / Revenue
8.8%
7.5%
Cash ConversionOCF / Net Profit
2.42×
0.67×
TTM Free Cash FlowTrailing 4 quarters
$50.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLLN
BLLN
ODC
ODC
Q4 25
$10.3M
Q3 25
$13.8M
$25.2M
Q2 25
$22.7M
Q1 25
$21.4M
Q4 24
$10.9M
Q3 24
$23.4M
Q2 24
$19.0M
Q1 24
$9.4M
Free Cash Flow
BLLN
BLLN
ODC
ODC
Q4 25
$1.3M
Q3 25
$6.5M
$17.1M
Q2 25
$16.0M
Q1 25
$16.4M
Q4 24
$-1.9M
Q3 24
$15.1M
Q2 24
$10.8M
Q1 24
$1.9M
FCF Margin
BLLN
BLLN
ODC
ODC
Q4 25
1.1%
Q3 25
7.7%
13.7%
Q2 25
13.8%
Q1 25
14.0%
Q4 24
-1.5%
Q3 24
13.3%
Q2 24
10.1%
Q1 24
1.8%
Capex Intensity
BLLN
BLLN
ODC
ODC
Q4 25
7.5%
Q3 25
8.8%
6.5%
Q2 25
5.8%
Q1 25
4.3%
Q4 24
10.0%
Q3 24
7.3%
Q2 24
7.7%
Q1 24
7.1%
Cash Conversion
BLLN
BLLN
ODC
ODC
Q4 25
0.67×
Q3 25
2.42×
1.93×
Q2 25
1.95×
Q1 25
1.66×
Q4 24
0.67×
Q3 24
2.74×
Q2 24
2.44×
Q1 24
0.76×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BLLN
BLLN

Prenatal$74.1M89%
Oncology$8.7M10%

ODC
ODC

Cat Litter$64.6M54%
Fluids Purification$26.7M22%
Agriculturaland Horticultural$12.9M11%
Industrialand Sports$11.6M10%
Animal Healthand Nutrition$4.7M4%

Related Comparisons